Intimation for Changes in Key Managerial Personnel dated November 28, 2023
Monitoring Agency Report for quarter ended September 30, 2023
Outcome of Board Meeting held on November 09, 2023.
Intimation for Schedule of Analyst/ Institutional Investor Meeting dated November 9, 2023.
Intimation for Earnings Call under Regulation 30 of the SEBI LODR, dated November 4, 2023
Prior Intimation for Board Meeting to be held on November 9, 2023
Allotment of Equity Shares on October 26, 2023 pursuant to exercise of ESOPs under ESOP Scheme 2016.
Closure of Trading Window dated 29th September, 2023
Intimation for Change in Senior Management Personnel dated 11 September, 2023
GHL ESOP Disclosure 2023 under SEBI SBEB & SE Regualtions, 2021
Intimation for Changes in Senior Management Personnel dated 23 Aug, 2023
Allotment of Equity Shares on August 18, 2023 pursuant to exercise of ESOPs under ESOP Scheme 2016.
Intimation under Reg. 30 of SEBI LODR, 2015 dated August 17, 2023
Monitoring Agency Report for quarter ended June 30, 2023
Outcome of Board Meeting held on 10 August, 2023
Allotment of Equity Shares on August 9, 2023 pursuant to exercise of ESOP under ESOP Scheme 2016.
Prior Intimation for Board Meeting to be held on August 10, 2023
Allotment of Equity Shares on July 24, 2023, pursuant to exercise of ESOP under ESOP Scheme 2016.
Closure of Trading Window dated 30 JUNE, 2023
Intimation under Reg. 30 of SEBI LODR, 2015 for Term Sheet
Allotment of Equity Shares on June 21, 2023, pursuant to exercise of ESOP under ESOP Scheme 2016.
Outcome of Board Meeting dated May 27, 2023
Intimation of Board Meeting to be held on 27 May, 2023
Monitoring Agency Report for quarter ended March 31, 2023
Closure of Trading Window dated 31st March, 2023
Outcome of Board Meeting dated March 27, 2023
Allotment of Equity Shares on 17th March, 2023, pursuant to exercise of ESOP under ESOP Scheme 2016.
Outcome of Board Meeting held on 13 February, 2023
Intimation of Board Meeting to be held on 13 February, 2023
Intimation for Postal Ballot Notice dated 22 December, 2022
Outcome of board meeting dated 22-Dec-2022
Details of Key Managerial Personnel under Regulation 30(5) of SEBI LODR, 2015
Details of Key Managerial Personnel under Regulation 30(5) of SEBI LODR, 2015
We love to hear about our doctors, facilities
and your treatment at Medanta.
The User agrees and acknowledges that the User has read, understood and accepts the terms and conditions contained in the brochure provided with the Device (“Device”) with respect to its usage, operations, return / replacement and warranty policy.
The User hereby agrees and acknowledges that the Device (hardware and software) used in the provision
of services by Medanta is being provided on “as is” and “as available” basis through Alivecor India Private
Limited. Neither does Medanta endorse or promote the Device in any manner nor will Medanta be liable
for any claims, representations or warranties, whether express or implied as to the safety, reliability,
durability and performance of the device.
The services once availed cannot be cancelled except in cases where the User requests to cancel the
service on the day of purchase in which case, full amount of service fees shall be refunded to the User
provided that the Device has not been unboxed.
Before the expiry of service duration, the User can extend the services by availing various program
options. For the said purposes, the User can call our helpline number +91 124 4141414 or visit
www.medanta.org. The extended program availed by the User shall be activated automatically on expiry of existing program of services.
In cases where the User has opted for availing the Services through rented Device, a refundable deposit amount of ₹ 5,000 (“Deposit Amount”) shall be applicable and paid by the User. The refund of Deposit Amount shall be subject to return of the Device in working and undamaged condition. Refund of Deposit Amount shall be made through the same mode of payment as that of purchase in cases where the User personally visits the Medanta for returning the Device. If the User opts to return the Device through post, Deposit Amount shall be refunded electronically thorough NEFT or Bank transfer by Medanta within seven (7) working days of receipt of the Device and receipt of scanned image/copy of the ‘Cancelled Cheque’ of the User’s bank account.
Upon expiry of the services (either in terms of number of ECG or duration of the program) availed by the
User, the Device has to be returned within ten (10) days failing which the Deposit Amount shall be
forfeited.
Please note that the ECG pack or Refundable Device deposit are non-transferable from one patient to
another.